IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Third Rock Ventures, LLC

Portfolio Profile

CIK: 0001600135 | BOSTON, MA

$1.1M
AUM
5
Positions
100%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Global Blood Therapeutics in14,760,900$622.3K58.10%
2Sage Therapeutics Inc(SG7)6,442,916$272.7K25.46%
3Blueprint Medicines Corp(2L9)7,393,059$157.8K14.73%
4Eleven Biotherapeutics Inc4,841,591$11.7K1.09%
5Zafgen Inc210,371$6.7K0.63%

Sector Allocation

Latest filing, equity positions only

Unclassified100% · $1.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Unclassified100%100%0%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %Change
Unclassified100%

AUM History

$353.0K | 3 pos.
$218.2M | 4 pos.
$178.8M | 4 pos.
$189.0M | 6 pos.
$344.9M | 6 pos.
$937.6K | 4 pos.
100%
0%
$960.8K | 4 pos.
$1.1M | 5 pos.
Q4
13
Q1
14
Q2
14
Q3
14
Q4
14
Q1
15
Q2
15
Q3
15

Recent Activity

Quarter-over-quarter position changes

1
New
0
Closed
0
Increased
2
Decreased
2
Unchanged